Cipla gets CDSCO Panel nod to study Revefenacin Inhalation solution Susmita Roy20 April 2025 12:30 PMNew Delhi: The pharmaceutical major Cipla has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Submit active controlled CT design for moderate to very severe COPD patients: CDSCO Panel tells Zydus Healthcare on Revefenacin inhalation Dr. Divya Colin16 Nov 2024 12:30 PMNew Delhi: Responding to Zydus Healthcare's proposal to manufacture and market Revefenacin Inhalation Solution 175 mcg/3ml, the Subject Expert...
Mylan Gets CDSCO Panel Nod To Study COPD drug Revefenacin inhalation solution Dr. Divya Colin18 July 2022 12:30 PMNew Delhi: Pharmaceutical major, Mylan Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under Central Drug...
Revefenacin helps patients with moderate to severe COPD Dr. Nandita Mohan5 Nov 2021 11:32 PMChronic obstructive pulmonary disease (COPD) is a leading cause of death and disability, investigation is essential for better management in both men...
Medical Bulletin 3/November/2021 Dr. Nandita Mohan3 Nov 2021 10:43 AMHere are Top Medical Stories of the dayBedtime Snacks Tied To Moderate Increase In Fasting Blood Sugar In Gestational Diabetes: StudyA recent study in...
Nebulized revefenacin improves health status of patients with moderate to very severe COPD: Study MD Editorial Team30 Oct 2021 4:15 AMChronic obstructive pulmonary disease (COPD) is a leading cause of death and disability, investigation is essential for better management in both men...
